Cargando…

Feasibility of [(18)F]fluoropivalate hybrid PET/MRI for imaging lower and higher grade glioma: a prospective first-in-patient pilot study

PURPOSE: MRI and PET are used in neuro-oncology for the detection and characterisation of lesions for malignancy to target surgical biopsy and to plan surgical resections or stereotactic radiosurgery. The critical role of short-chain fatty acids (SCFAs) in brain tumour biology has come to the forefr...

Descripción completa

Detalles Bibliográficos
Autores principales: Islam, Shahriar, Inglese, Marianna, Grech-Sollars, Matthew, Aravind, Preetha, Dubash, Suraiya, Barwick, Tara D., O’Neill, Kevin, Wang, James, Saleem, Azeem, O’Callaghan, James, Anchini, Giulio, Williams, Matthew, Waldman, Adam, Aboagye, Eric O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611885/
https://www.ncbi.nlm.nih.gov/pubmed/37490079
http://dx.doi.org/10.1007/s00259-023-06330-0
_version_ 1785128583889420288
author Islam, Shahriar
Inglese, Marianna
Grech-Sollars, Matthew
Aravind, Preetha
Dubash, Suraiya
Barwick, Tara D.
O’Neill, Kevin
Wang, James
Saleem, Azeem
O’Callaghan, James
Anchini, Giulio
Williams, Matthew
Waldman, Adam
Aboagye, Eric O.
author_facet Islam, Shahriar
Inglese, Marianna
Grech-Sollars, Matthew
Aravind, Preetha
Dubash, Suraiya
Barwick, Tara D.
O’Neill, Kevin
Wang, James
Saleem, Azeem
O’Callaghan, James
Anchini, Giulio
Williams, Matthew
Waldman, Adam
Aboagye, Eric O.
author_sort Islam, Shahriar
collection PubMed
description PURPOSE: MRI and PET are used in neuro-oncology for the detection and characterisation of lesions for malignancy to target surgical biopsy and to plan surgical resections or stereotactic radiosurgery. The critical role of short-chain fatty acids (SCFAs) in brain tumour biology has come to the forefront. The non-metabolised SCFA radiotracer, [(18)F]fluoropivalate (FPIA), shows low background signal in most tissues except eliminating organs and has appropriate human dosimetry. Tumour uptake of the radiotracer is, however, unknown. We investigated the uptake characteristics of FPIA in this pilot PET/MRI study. METHODS: Ten adult glioma subjects were identified based on radiological features using standard-of-care MRI prior to any surgical intervention, with subsequent histopathological confirmation of glioma subtype and grade (lower-grade – LGG – and higher-grade – HGG – patients). FPIA was injected as an intravenous bolus injection (range 342–368 MBq), and dynamic PET and MRI data were acquired simultaneously over 66 min. RESULTS: All patients tolerated the PET/MRI protocol. Three patients were reclassified following resection and histology. Tumour maximum standardised uptake value (SUV(max,60)) increased in the order LGG (WHO grade 2) < HGG (WHO grade 3) < HGG (WHO grade 4). The net irreversible solute transfer, Ki, and influx rate constant, K1, were significantly higher in HGG (p < 0.05). Of the MRI variables studied, DCE-MRI-derived extravascular-and-extracellular volume fraction (v(e)) was high in tumours of WHO grade 4 compared with other grades (p < 0.05). SLC25A20 protein expression was higher in HGG compared with LGG. CONCLUSION: Tumoural FPIA PET uptake is higher in HGG compared to LGG. This study supports further investigation of FPIA PET/MRI for brain tumour imaging in a larger patient population. CLINICAL TRIAL REGISTRATION: Clinicaltrials.gov, NCT04097535. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00259-023-06330-0.
format Online
Article
Text
id pubmed-10611885
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-106118852023-10-29 Feasibility of [(18)F]fluoropivalate hybrid PET/MRI for imaging lower and higher grade glioma: a prospective first-in-patient pilot study Islam, Shahriar Inglese, Marianna Grech-Sollars, Matthew Aravind, Preetha Dubash, Suraiya Barwick, Tara D. O’Neill, Kevin Wang, James Saleem, Azeem O’Callaghan, James Anchini, Giulio Williams, Matthew Waldman, Adam Aboagye, Eric O. Eur J Nucl Med Mol Imaging Original Article PURPOSE: MRI and PET are used in neuro-oncology for the detection and characterisation of lesions for malignancy to target surgical biopsy and to plan surgical resections or stereotactic radiosurgery. The critical role of short-chain fatty acids (SCFAs) in brain tumour biology has come to the forefront. The non-metabolised SCFA radiotracer, [(18)F]fluoropivalate (FPIA), shows low background signal in most tissues except eliminating organs and has appropriate human dosimetry. Tumour uptake of the radiotracer is, however, unknown. We investigated the uptake characteristics of FPIA in this pilot PET/MRI study. METHODS: Ten adult glioma subjects were identified based on radiological features using standard-of-care MRI prior to any surgical intervention, with subsequent histopathological confirmation of glioma subtype and grade (lower-grade – LGG – and higher-grade – HGG – patients). FPIA was injected as an intravenous bolus injection (range 342–368 MBq), and dynamic PET and MRI data were acquired simultaneously over 66 min. RESULTS: All patients tolerated the PET/MRI protocol. Three patients were reclassified following resection and histology. Tumour maximum standardised uptake value (SUV(max,60)) increased in the order LGG (WHO grade 2) < HGG (WHO grade 3) < HGG (WHO grade 4). The net irreversible solute transfer, Ki, and influx rate constant, K1, were significantly higher in HGG (p < 0.05). Of the MRI variables studied, DCE-MRI-derived extravascular-and-extracellular volume fraction (v(e)) was high in tumours of WHO grade 4 compared with other grades (p < 0.05). SLC25A20 protein expression was higher in HGG compared with LGG. CONCLUSION: Tumoural FPIA PET uptake is higher in HGG compared to LGG. This study supports further investigation of FPIA PET/MRI for brain tumour imaging in a larger patient population. CLINICAL TRIAL REGISTRATION: Clinicaltrials.gov, NCT04097535. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00259-023-06330-0. Springer Berlin Heidelberg 2023-07-25 2023 /pmc/articles/PMC10611885/ /pubmed/37490079 http://dx.doi.org/10.1007/s00259-023-06330-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Islam, Shahriar
Inglese, Marianna
Grech-Sollars, Matthew
Aravind, Preetha
Dubash, Suraiya
Barwick, Tara D.
O’Neill, Kevin
Wang, James
Saleem, Azeem
O’Callaghan, James
Anchini, Giulio
Williams, Matthew
Waldman, Adam
Aboagye, Eric O.
Feasibility of [(18)F]fluoropivalate hybrid PET/MRI for imaging lower and higher grade glioma: a prospective first-in-patient pilot study
title Feasibility of [(18)F]fluoropivalate hybrid PET/MRI for imaging lower and higher grade glioma: a prospective first-in-patient pilot study
title_full Feasibility of [(18)F]fluoropivalate hybrid PET/MRI for imaging lower and higher grade glioma: a prospective first-in-patient pilot study
title_fullStr Feasibility of [(18)F]fluoropivalate hybrid PET/MRI for imaging lower and higher grade glioma: a prospective first-in-patient pilot study
title_full_unstemmed Feasibility of [(18)F]fluoropivalate hybrid PET/MRI for imaging lower and higher grade glioma: a prospective first-in-patient pilot study
title_short Feasibility of [(18)F]fluoropivalate hybrid PET/MRI for imaging lower and higher grade glioma: a prospective first-in-patient pilot study
title_sort feasibility of [(18)f]fluoropivalate hybrid pet/mri for imaging lower and higher grade glioma: a prospective first-in-patient pilot study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611885/
https://www.ncbi.nlm.nih.gov/pubmed/37490079
http://dx.doi.org/10.1007/s00259-023-06330-0
work_keys_str_mv AT islamshahriar feasibilityof18ffluoropivalatehybridpetmriforimaginglowerandhighergradegliomaaprospectivefirstinpatientpilotstudy
AT inglesemarianna feasibilityof18ffluoropivalatehybridpetmriforimaginglowerandhighergradegliomaaprospectivefirstinpatientpilotstudy
AT grechsollarsmatthew feasibilityof18ffluoropivalatehybridpetmriforimaginglowerandhighergradegliomaaprospectivefirstinpatientpilotstudy
AT aravindpreetha feasibilityof18ffluoropivalatehybridpetmriforimaginglowerandhighergradegliomaaprospectivefirstinpatientpilotstudy
AT dubashsuraiya feasibilityof18ffluoropivalatehybridpetmriforimaginglowerandhighergradegliomaaprospectivefirstinpatientpilotstudy
AT barwicktarad feasibilityof18ffluoropivalatehybridpetmriforimaginglowerandhighergradegliomaaprospectivefirstinpatientpilotstudy
AT oneillkevin feasibilityof18ffluoropivalatehybridpetmriforimaginglowerandhighergradegliomaaprospectivefirstinpatientpilotstudy
AT wangjames feasibilityof18ffluoropivalatehybridpetmriforimaginglowerandhighergradegliomaaprospectivefirstinpatientpilotstudy
AT saleemazeem feasibilityof18ffluoropivalatehybridpetmriforimaginglowerandhighergradegliomaaprospectivefirstinpatientpilotstudy
AT ocallaghanjames feasibilityof18ffluoropivalatehybridpetmriforimaginglowerandhighergradegliomaaprospectivefirstinpatientpilotstudy
AT anchinigiulio feasibilityof18ffluoropivalatehybridpetmriforimaginglowerandhighergradegliomaaprospectivefirstinpatientpilotstudy
AT williamsmatthew feasibilityof18ffluoropivalatehybridpetmriforimaginglowerandhighergradegliomaaprospectivefirstinpatientpilotstudy
AT waldmanadam feasibilityof18ffluoropivalatehybridpetmriforimaginglowerandhighergradegliomaaprospectivefirstinpatientpilotstudy
AT aboagyeerico feasibilityof18ffluoropivalatehybridpetmriforimaginglowerandhighergradegliomaaprospectivefirstinpatientpilotstudy